Investing.com - Amarin (NASDAQ:AMRN) reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Amarin announced earnings per share of $-0.06 on revenue of $4.6M. Analysts polled by Investing.com anticipated EPS of $-0.0138 on revenue of $129.42M.
Amarin shares are down 14% from the beginning of the year, still down 54.10% from its 52 week high of $5.97 set on August 23, 2021. They are under-performing the S&P 500 which is down 12.39% from the start of the year.
Amarin shares lost 3.28% in pre-market trade following the report.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar